Salbutamol (Direct-Haler AS)

N/A

Report date: 2025/10/24 17:59:50

Base Information

Drug NameSalbutamol (Direct-Haler AS)
Drug Alias Namesalbutamol
ClassificationSmall molecules
Mechanisms of ActionBeta-2 adrenergic receptor agonists
TargetsBeta-2 adrenergic receptor
Therapy Area/IndicationsAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItalyDenmark
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesDirect-Haler AS
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesZambonDirect-Haler AS
Active IndicationsN/A
Inactive IndicationsAsthma

Other Information

ATC CodeN/A
Related LinksN/A